Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

AGC Biologics is partnering with ATUM to integrate technology designed to increase yields and shorten the path to clinical trials.

The vaccine developers market shows significant opportunities through increased demand, collaborative partnerships, and ...

A new review in Chinese Medical Journal details progress in nanocarrier-based cancer therapy. It analyzes polymeric, lipidic, ...

There are few forms of the botanical world as readily identifiable as fern leaves. These often large, lacy fronds lend ...

Nov 19 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the ...

In a development that could shape cancer treatment strategies, researchers have found evidence that COVID mRNA vaccines can enhance the effectiveness of cancer immunotherapy and significantly improve ...

Also at the mRNA conference, Applied DNA will feature its IVT Discovery Kit, a powerful platform for evaluating and optimizing in vitro transcription (IVT). Meet our teams and discover for yourself ...

Deborah Fuller receives funding from the National Institutes of Health. She is co-founder and a scientific advisor for two biotech companies developing nucleic acid vaccine technologies that are not ...

Few medical advances in recent memory have sparked as much controversy as COVID-19 vaccines utilizing mRNA (messenger RNA). Currently, there are two such vaccines, from Pfizer-BioNTech and Moderna.

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...